The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 640.00 M

The Chemours Company EBITDA is USD 640.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 753.33% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 75.00 M, a -92.72% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.03 B, a -15.02% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.21 B, a 59.89% change year over year.
  • The Chemours Company EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 758.00 M, a 104.86% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)